We are pleased to invite you to the inaugural lecture of Univ.-Prof.in MMag.a Dr.in Dagmar Stoiber-Sakaguchi Professor of Pharmacology.
WHAT SIGNALS LEAD TO CANCER? POSSIBLE PHARMACOLOGICAL TARGETS
Pharmacology is concerned with the interactions of active substances and biological systems. How cells react to signals from their environment or can also contact other cells is regulated by signalling cascades that extend from the cell surface to the cell nucleus. Alterations in signalling pathways are therefore the basis of many cancers.
For many types of cancer, these deviations and their effects on the cell and organism during the course of the disease are not yet fully understood. Understanding the molecular mechanisms underlying cancer is an essential building block for the future development of new drug therapies.
The inaugural lecture will provide insights into the field of basic oncological research and present new findings on individual components of signalling pathways in the tumour cells themselves, as well as in immune cells that have the ability to control tumour growth. This allows perspectives on the development of improved approaches for the diagnosis, prognosis and therapy of cancers such as leukaemias.
Univ.-Prof. Dr. Rudolf Mallinger
Rector of Karl Landsteiner University of Health Sciences
Head of the Institute of Pharmacology, Head of the Center for Physiology and Pharmacology, Medical University of Vienna
Univ.-Prof.in MMag.a Dr.in Dagmar Stoiber-Sakaguchi
Please register until 15th May 2033 via MS Formular.
Due to the current Covid regulations at KL, a maximum of 60 people may be admitted to the KL Auditorium. Should the permitted number of people be exceeded in the course of registrations, we would have to proceed on a first-come-first-served basis to avoid overcrowding and would inform you of this by 20 May 2022.